Intrahepatic Cholangiocarcinoma — Trials

Intrahepatic Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 86
Recruiting: 52
Ph III recruiting: 2
Growth YoY: +14.3%
Industry share: 9%
Top sponsor: Shanghai Zhongshan Hospital
Termination share: 47.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (31)

clinicaltrialsPublishedShowing 1–26 of 26 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07768085	Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT	not yet recruiting	N/A	40,000	Shengjing HospitalOTHER	1	Aug 17, 2026	clinicaltrials
NCT07760038	Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury	recruiting	N/A	30	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Aug 12, 2026	clinicaltrials